The Cancer Biology (CB) Research Program is composed of 46 Research Members and 25 Members from 15 basic science and clinical departments at Baylor College of Medicine. The Program members perform basic research in a diverse array of cancer and cancer-related research projects. The Cancer Biology Program has three major themes: (1) Human cancer pathways, (2) Mouse models of Cancer, and (3) Cancer Genomics and Bioinformatics. The vast majority of Research Members of the Program are principal investigators on NIH-funded grants. The program had a total of $4,610,725 support from the NCI last year and overall received $12,247,835 in peer-reviewed funding. Since being rated as an excellent to outstanding program in the initial review, the Cancer Biology Program has worked to build on its strengths of scientific productivity and a strong cadre of mouse cancer model specialists. In addition, the Program has increased the number of intra-programmatic and inter-programmatic collaborations as evidenced in its members publication record over the last three years. Approximately 300 cancer-related publications have been published by Research Members from 2006-2009 and 15% of these publications are intra-programmatic and 29% are inter-programmatic in nature. Finally, to remedy a perceived early weakness, the Program has greatly enhanced its interactions with the Baylor Human Genome Sequencing Center and has organized a thematic group of cancer genomics and bioinformatics experts. The Cancer Biology Program has almost doubled its membership from the last review and collaborations and interactions have increased in part because of Program meetings, sponsored speakers, symposia, and pilot project funding initiatives. The collaborative efforts among Cancer Biology Program members was recently evidenced by the participation of seven members in The Cancer Genome Atlas multi-institutional consortium to map the genetic, epigenetic and transcriptomic alterations in glioblastomas and ovarian cancers. The Program Leader is Lawrence A Donehower, Ph.D. and the Program co-Leader is Francesco DeMayo, Ph.D.

Public Health Relevance

Scientists in the Cancer Biology Program of the Dan L. Duncan Cancer Center perform research on changes in cellular processes that cause a normal cell to become a cancer cell. Understanding these basic changes will facilitate the development of more effective cancer therapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-08
Application #
8690542
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
8
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77030
Guarducci, Cristina; Bonechi, Martina; Benelli, Matteo et al. (2018) Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. NPJ Breast Cancer 4:38
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Xing, Zhen; Zhang, Yanyan; Liang, Ke et al. (2018) Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer. Cancer Res 78:4524-4532
Creighton, Chad J (2018) The clinical applications of The Cancer Genome Atlas project for bladder cancer. Expert Rev Anticancer Ther 18:973-980
Szwarc, Maria M; Hai, Lan; Gibbons, William E et al. (2018) Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics Reproduction 156:387-395
Nguyen, Tuan M; Kabotyanski, Elena B; Dou, Yongchao et al. (2018) FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res 78:4229-4240
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Chiang, Angie C A; Fowler, Stephanie W; Savjani, Ricky R et al. (2018) Combination anti-A? treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med 215:1349-1364
Zhang, Yan; Zheng, Dayong; Zhou, Ting et al. (2018) Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nat Commun 9:4080
Grzeskowiak, Caitlin L; Kundu, Samrat T; Mo, Xiulei et al. (2018) In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732

Showing the most recent 10 out of 991 publications